EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Severe acute respiratory syndrome coronavirus 2 vaccination associates with upregulated expression of ferritin heavy chain-1 and transferrin receptor

Mohammad G. Mohammad, Nada Mazen Farhat, Ameera Abu-Qiyas, Jasmin Shafarin, Bilal Rah, Nour Dallal, Wassim El Baba, Fatima Bukhalaf, Ameera Askari, Mohamad Madkhour, Jibran Sualeh Muhammad, Mawieh Hamad

Advances in Biomedical and Health Sciences · 2025

DOI: 10.4103/abhs.abhs_115_24 ↗
AbstractBibliografische Angaben

Abstract

Background: High serum ferritin (hyperferritinemia) is a routine finding in individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and a reliable marker of coronavirus disease 2019 severity. We previously observed hypomethylation of the ferritin heavy chain-1 ( FTH1 ) gene induced by the SARS-CoV-2 spike protein. Given that this protein is present in the majority of SARS-CoV-2 vaccines, the question of whether such vaccines can induce epigenetic changes and alter the pattern of FTH1 expression to induce hyperferritinemia is yet to be explored. Methods: Blood samples from 84 healthy individuals who received one or more jabs of Sinopharm and/or Pfizer vaccines or were not vaccinated were assessed for plasma ferritin levels and the expression of FTH1 and transferrin receptor ( TFRC ) genes. The expression of ten-eleven translocation ( TETs 1–3 ) methylcytosine dioxygenases that facilitate cytosine demethylation and DNA methyltransferases ( DNMTs 1, 3A and 3B ), which mediate cytosine methylation was also examined. Results: Our results showed that plasma ferritin levels in vaccinated individuals were slightly, but not significantly, higher than those in unvaccinated controls. However, the expression of FTH1 and TFRC genes was significantly upregulated in vaccinated individuals compared to that in controls. Moreover, the expression of TETs 1-3 and DNMTs 1 , 3A , and 3B was significantly higher in the vaccinated individuals than in the controls. Conclusion: These findings suggest that SARS-CoV-2 vaccination is associated with significant epigenetic reprogramming that upregulates FTH1 and TFRC expression without precipitating hyperferritinemia. This indicates that individuals vaccinated against SARS-CoV-2 have minimal or no risk of chronic inflammation or tissue damage related to hyperferritinemia.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →